Dietary cassava, β-cell function and hyperbolic product loss rate in type 2 diabetes patients from South Kivu

Diabetes and Metabolism

Volumn 36, Issue 2, 2010, Pages 108-113

  Manwa, B ^a   Kashongwe, Z ^a   Bahindwa, B ^a   Kolanowski, J ^b   Hermans, M P ^b  

^a CATHOLIC UNIVERSITY OF BUKAVU   (Democratic Republic Congo)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

cell function; Cassava; Sub Saharan Africa; Type 2 diabetes

Indexed keywords

GLUCOSE; INSULIN; LIPID; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BODY FAT; BODY MASS; BREAD; CARBOHYDRATE INTAKE; CASSAVA; CONGO; DIABETIC PATIENT; DIET RESTRICTION; DIETARY INTAKE; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LEGUME; LIPID BLOOD LEVEL; MAIZE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PHENOTYPE; POTATO; RICE; SORGHUM; WAIST CIRCUMFERENCE;

ADULT; AGED; ANALYSIS OF VARIANCE; CARBOHYDRATE METABOLISM; CONGO; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIET; FEMALE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MALE; MANIHOT; MIDDLE AGED; PHENOTYPE;

EID: 77953475926     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2009.08.001     Document Type: Article

References (32)

1. Rudenski A.S., Hadden D.R., Atkinson A.B., Kennedy L., Matthews D.R., Merrett J.D., et al. Natural history of pancreatic islet B-cell function in Type 2 diabetes mellitus studied over 6 years by Homeostasis Model Assessment. Diabet Med 5 (1988) 36-41
2. Levy J., Atkinson A.B., Bell P.M., McCance D.R., and Hadden D.R. Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study. Diabet Med 15 (1998) 290-296
3. Turner R.C., Cull C.A., Frighi V., and Holman R.R. Glycemic control with diet, sulfonylurea, metformin or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 281 (1999) 2005-2012
4. Bagust A., and Beale S. Deteriorating beta-cell function in type 2 diabetes: a long-term model. Q J Med 96 (2003) 281-288
5. Kahn S.E., Haffner S.M., Heise M.A., Herman W.H., Holman R.R., Jones N.P., et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 355 (2006) 2427-2443
6. Yessoufou A., Ategbo J.M., Girard A., Prost J., Dramane K.L., Moutairou K., et al. Cassava-enriched diet is not diabetogenic, rather it aggravates diabetes in rats. Fundam Clin Pharmacol 20 (2006) 579-586
7. Banea M., Poulter N.H., and Rosling H. Shortcuts in cassava processing and risk of dietary cyanide exposure in Zaire. Food Nutr Bull 14 (1992) 137-143
8. Tylleskär T., Banea M., Bikangi N., Nahimana G., Persson L.A., and Rosling H. Dietary determinants of a non-progressive spastic paraparesis (Konzo): a case-referent study in a high incidence area of Zaire. Int J Epidemiol 24 (1995) 949-956
9. Kamalu B.P. The adverse effects of long-term cassava (Manihot esculenta Crantz) consumption. Int J Food Sci Nutr 46 (1995) 65-93
10. Thissen J.P., and Hermans M.P. Aliments fonctionnels et diabète. In: Roberfroid (Ed). Les Aliments Fonctionnels (2002), Sciences & Techniques Agro-alimentaires, Éditions TEC et DOC, Paris 245-278
11. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.
12. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
13. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
14. Levy J.C., Matthews D.R., and Hermans M.P. Correct Homeostasis Model Assessment (HOMA) evaluation uses the computer program. Diabetes Care 21 (1998) 2191-2192
15. Hermans M.P., Levy J., Morris R.J., and Turner R.C. Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes. Diabetes 48 (1999) 1779-1786
16. Hermans M.P., Levy J., Morris R.J., and Turner R.C. Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia 42 (1999) 678-687
17. Kahn S.E., Prigeon R.L., Mc Culloch D.K., Boyko E.J., Berman R.N., Schwartz M.W., et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42 (1993) 1663-1672
18. Bergman R.N., Watanabe R., Rebrin K., Ader M., and Steil G. Toward an integrated phenotype in pre-NIDDM. Diabet Med 13 (1996) S67-S77
19. Bergman R.N. Pathogenesis and prediction of diabetes mellitus: lessons from integrative physiology. Mt Sinai J Med 69 (2002) 280-290
20. Albareda M., Rodríguez-Espinosa J., Murugo M., de Leiva A., and Corcoy R. Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test. Diabetologia 43 (2000) 1507-1511
21. Utzschneider K.M., Prigeon R.L., Carr D.B., Hull R.L., Tong J., Shofer J.B., et al. Impact of differences in fasting glucose and glucose tolerance on the hyperbolic relationship between insulin sensitivity and insulin responses. Diabetes Care 29 (2006) 356-362
22. Bergman R.N. Banting lecture 2006. Orchestration of glucose homestasis. From a small acorn to California oak. Diabetes 56 (2007) 1489-1501
23. Guerrero-Romero F. Rodriguez-Moran: Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus. Eur J Clin Invest 36 (2006) 796-802
24. Munoko T.N., and Hermans M.P. Phenotypic characterization of 1st generation Maghrebian migrants with type 2 diabetes. A gender-based comparison with a reference North-Caucasian Belgian cohort. Diabetes Metab Syndr 2 (2008) 115-124
25. Preumont V., Hermans M.P., Lebecque P., and Buysschaert M. Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with gene CFTR ΔF 508 mutation. Diabetes Care 30 (2007) 1187-1192
26. Oriot P.H., Feys J.L., Mertens de Wilmars S., Misson A., Ayache L., Fagnart O., et al. Insulin sensitivity, adjusted β-cell function and adiponectinemia among lean drug-naïve schizophrenic subjects treated with atypical antipsychotic drugs: a 9-month prospective study. Diabetes Metab 34 (2008) 490-496
27. Hermans M.P. Diabetic macro- and microvascular disease in type 2 diabetes. Diabetes Vasc Dis Res 4 (2007) S7-S11
28. Dehout F., Haumont S., Gaham N., Amoussou-Guenou K.D., and Hermans M.P. Metabolic syndrome in Bantu subjects with type 2 diabetes from sub-Saharan extraction: prevalence, gender differences and HOMA-hyperbolic product. Diabetes Metab Syndr 2 (2008) 5-11
29. Simon O.R., and Gaskin R. Supporting evidence for the use of cassava (Manihot esculeta) products instead of wheat flour products in the diet of the diabetic. West Indian Med J 37 (1988) 100-105
30. Swai A.B., Mclarty D.G., Mtinangi B.L., Tatala S., Kitange H.M., Mlingi N., et al. Diabetes is not caused by cassava toxicity. A study in a Tanzanian community. Diabetes Care 15 (1992) 1378-1385
31. Foster-Powell K., Holt S.H.A., and Brand-Miller J.C. International table of glycemic index and glycemic load values: 2002. Am J Clin Nut 76 (2002) 5-56
32. Mbanya J.C., Mfopou J.K., Sobngwi E., Mbanya D.N., and Ngogang J.Y. Metabolic and hormonal effects of five common African diets eaten as mixed meals: the Cameroon Study. Eur J Clin Nutr 57 (2003) 580-585